Credit Suisse says this stock can surge 100%, citing an opportunity in obesity-related hypertension
Law's price target of $40 implies upside of more than 100% over the next 12 months from where it ended Monday's session. "There is a large unmet need in resistant HTN," he said in a note to clients Tuesday, adding that Mineralys has "potential best-in-class data through a targeted and methodical approach." HTN is used as shorthand for hypertension.
He cited conversations with cardiologists and nephrologists, who said they would be open to prescribing lorundrostat instead of generic alternatives. To be sure, there are still questions the company has yet to answer. Though results look strong, potassium levels still appear to be high with lorundrostat, Law said. More phases and further data are also expected in the coming years.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
6 Stocks to Bet On Amid ChatGPT AI Boom: Credit SuisseHow to invest in the ChatGPT-driven AI boom: Credit Suisse shares 6 stocks they're labeling as 'top picks' as their exposure to AI development opens them up to new revenue streams
Consulte Mais informação »
Former top Credit Suisse shareholder sells full stake in bank - FTHarris Associates, one of Credit Suisse's longest major shareholders, has sold its entire stake in the Swiss bank after losing patience with its strategy to stop persistent losses and a client exodus, the Financial Times reported on Sunday.
Consulte Mais informação »
Former top Credit Suisse shareholder sells full stake in bankHarris Associates, one of Credit Suisse's major shareholders, has sold its stake in the Swiss bank over the past few months, the deputy chairman and chief investment officer of the activist Chicago-based investor, David Herro, said on Sunday.
Consulte Mais informação »
One of Credit Suisse's largest shareholders sells its stake after two-decades of holding: reportOne of Credit Suisse’s biggest shareholders, Harris Associates, has sold off its entire position in the beleaguered bank after two decades at the helm, The...
Consulte Mais informação »
Credit Suisse shareholder Harris Associates exits entire stakeLong-time Credit Suisse shareholder Harris Associates reportedly sold its entire stake in the embattled bank
Consulte Mais informação »
FLOKI Enters Top 100 Following 15% Daily Surge: Market WatchAlthough most of the market continues to be stagnant, FLOKI has shot up in the top 100.
Consulte Mais informação »